Table: Peptidream -2018/19 parent results
Aug 8 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended 6 months to NEXT
Jun 30, 2019 Jun 30, 2018 Dec 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 7.22 6.43
(+12.3 pct) (+31.3 pct)
Operating 3.58 2.91
(+23.0 pct) (+16.9 pct)
Recurring 3.81 3.15
(+20.7 pct) (+20.2 pct)
Net 2.77 2.34
(+18.6 pct) (+23.5 pct)
EPS 22.42 yen 19.35 yen
EPS Diluted 21.33 yen 17.79 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner